Sample size and power calculations in repeated measurement analysis

Chul Ahn, John E. Overall, Scott Tonidandel

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.

Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalComputer Methods and Programs in Biomedicine
Volume64
Issue number2
DOIs
StatePublished - Feb 2001

Fingerprint

Sample Size
Computer program listings
Software
Controlled Clinical Trials
Testing
Research

Keywords

  • Dropouts
  • Power calculation
  • Repeated measures
  • Sample size estimate

ASJC Scopus subject areas

  • Software

Cite this

Sample size and power calculations in repeated measurement analysis. / Ahn, Chul; Overall, John E.; Tonidandel, Scott.

In: Computer Methods and Programs in Biomedicine, Vol. 64, No. 2, 02.2001, p. 121-124.

Research output: Contribution to journalArticle

Ahn, Chul ; Overall, John E. ; Tonidandel, Scott. / Sample size and power calculations in repeated measurement analysis. In: Computer Methods and Programs in Biomedicine. 2001 ; Vol. 64, No. 2. pp. 121-124.
@article{0b81ef8d85fd4051ba0643d0c99490bc,
title = "Sample size and power calculations in repeated measurement analysis",
abstract = "Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.",
keywords = "Dropouts, Power calculation, Repeated measures, Sample size estimate",
author = "Chul Ahn and Overall, {John E.} and Scott Tonidandel",
year = "2001",
month = "2",
doi = "10.1016/S0169-2607(00)00095-X",
language = "English (US)",
volume = "64",
pages = "121--124",
journal = "Computer Methods and Programs in Biomedicine",
issn = "0169-2607",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Sample size and power calculations in repeated measurement analysis

AU - Ahn, Chul

AU - Overall, John E.

AU - Tonidandel, Scott

PY - 2001/2

Y1 - 2001/2

N2 - Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.

AB - Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.

KW - Dropouts

KW - Power calculation

KW - Repeated measures

KW - Sample size estimate

UR - http://www.scopus.com/inward/record.url?scp=0035255228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035255228&partnerID=8YFLogxK

U2 - 10.1016/S0169-2607(00)00095-X

DO - 10.1016/S0169-2607(00)00095-X

M3 - Article

C2 - 11137194

AN - SCOPUS:0035255228

VL - 64

SP - 121

EP - 124

JO - Computer Methods and Programs in Biomedicine

JF - Computer Methods and Programs in Biomedicine

SN - 0169-2607

IS - 2

ER -